Stock Trading Ideas

Rocket Lab's Next Launch In 4 Days — Is RKLB Ready For Liftoff?

Why Smart Money Is Spreading Out: ETF Flows Signal Surge In Portfolio Diversification

Stanley Druckenmiller-Backed PureCycle Eyes $600M Payday

Why Smart Money Is Spreading Out: ETF Flows Signal Surge In Portfolio Diversification

Stanley Druckenmiller-Backed PureCycle Eyes $600M Payday

This Chinese Herb Stock Is Now Bigger Than Super Micro And Reddit

These 3 Gold Stocks Have Rocketed 50%, Thanks To A Floundering Dollar

This Chinese Herb Stock Is Now Bigger Than Super Micro And Reddit

These 3 Gold Stocks Have Rocketed 50%, Thanks To A Floundering Dollar

Hinge Health's Tech Is Primed To Capture America's Untapped MSK Pain Market: Analyst

Big Money Dumps SPY, But History Says Don't Panic

Trading Ideas Recent News

Sunrun Receives Downgrade As Analyst Warns Business Model Relies On Inflated System Values For Tax Credits

Sunrun (RUN) shares downgraded to Sell due to financial disclosure revealing $600/system loss and inability to sell tax credits, as well as circular cash burn problem.

Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency

Fresenius Medical Care outlines new strategy with 5008X machine rollout in the U.S., launch of Value-Based Care segment, and cost-saving goals through FME25+.

Taboola Draws Analyst Praise For Meta-Like AI, Exclusive Ad Deals, Growing Role In CTV, Display Ads

Needham analyst maintains Buy rating and raises price target for Taboola due to its unique data, AI technology, exclusive deals, and expanding TAM through Realize platform and Yahoo partnership.

Accenture Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

US Stocks Lower; Retail Sales Decline In May

Nvidia To Rally More Than 38%? Here Are 10 Top Analyst Forecasts For Tuesday

Mineralys Therapeutics: Investigational Drug Shows Benefit In Hypertensive Patients With Chronic Kidney Disease, Stock Jumps

Mineralys reports Phase 2 trial success for lorundrostat, showing BP and kidney improvements in CKD patients with favorable safety results.

Trump Wants Babies To Get $1,000 To Invest At Birth: This Maginicent 7 Stock Tops Poll For 18-Year Growth

If Donald Trump's plan for $1,000 government-funded investment accounts for babies go through, this is the Mag 7 stock Benzinga readers would pick to invest in.

Surgery Partners Rejects Bain Capital's Private Buyout Offer, Will Remain Independent

Surgery Partners rejects Bain Capital's acquisition bid, citing greater long-term value as a public company with strong growth potential and strategic plans.

This Enphase Energy Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

This Cooper Companies Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday

Sunrun, First Solar Plunge—Solar Stocks Hit Hard By Trump Tax Bill: Latest

Solar stocks fall sharply on Tuesday after theSenate unveiled its version of Trump's tax bill, slashing renewable energy incentives.

HCA Healthcare Climbs 3.6% After Key Trading Signal

A significant trading signal occurred for HCA Healthcare stock, as it demonstrated a power inflow at $355.95, after which HCA rose up to 3.6%.

Top 3 Health Care Stocks That Are Ticking Portfolio Bombs

Applied Materials, Disney And A Utilities Stock: CNBC's 'Final Trades'

Disney and Applied Materials are breaking out, with strong year-to-date gains. Vistra Corp. is also seen as a strong utilities stock.